title: The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection.
abstract: The therapeutic efficacy of liposomal cefoperazone against Pseudomonas aeruginosa was investigated in a granulocytopenic mouse model of acute lung infection. Granulocytopenia was induced in mice by intraperitoneal (i.p.) injection of 200 mg/kg cyclophosphamide. Mice were challenged by exposure to an aerosol containing P. aeruginosa and were treated i.p. with liposomal cefoperazone prepared by the dehydration-rehydration method. The half-life of free cefoperazone in the lungs following i.p. administration of the liposomal drug was significantly lengthened (13 min vs. 261 min), and the cefoperazone activity in the lungs remained above the MIC longer after administration of liposomal cefoperazone than after treatment with cefoperazone. Liposomal cefoperazone was more effective than cefoperazone alone in preventing death of granulocytopenic mice from lethal pulmonary challenge with P. aeruginosa (75% vs. 38% survival, p = 0.031). Finally, P. aeruginosa was cleared faster from the lungs of mice treated with liposomal cefoperazone when compared with those treated with cefoperazone. This study shows that incorporation of cefoperazone into liposomes enhances the activity of the antibiotic against P. aeruginosa in a granulocytopenic host.
authors.affiliation: Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
authors.forename: P H
authors.initials: PH
authors.lastname: Di Rocco
authors.forename: M C
authors.initials: MC
authors.lastname: Nacucchio
authors.forename: D O
authors.initials: DO
authors.lastname: Sordelli
authors.forename: F
authors.initials: F
authors.lastname: Mancuso
authors.forename: A M
authors.initials: AM
authors.lastname: Hooke
mesh_terms: D000208:Acute Disease; D000380:Agranulocytosis / Q000150:complications*; D000818:Animals; D002438:Cefoperazone / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D004337:Drug Carriers; D006207:Half-Life; D008081:Liposomes; D008168:Lung / Q000378:metabolism / Q000382:microbiology; D008171:Lung Diseases / Q000150:complications / Q000188:drug therapy*; D051379:Mice; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D002438:Cefoperazone